Health Care / Medicine

A Look At How The Law Fails Patients

A look at the intersection of civil rights and health care.

How Healthcare Leaders Are Responding To The Supreme Court’s Preventive Care Ruling

SCOTUS upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded the decision, though some concerns remain.

What VCs Have Learned About Health Tech In The Public Markets

Two digital health companies have gone public this year: Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech in the public markets.

The MFN Executive Order: A Global Reset For U.S. Pharma

It's a bold attempt to recalibrate global drug pricing — with U.S. patients at the center. But without clear enforcement, legal grounding, or international cooperation, its future remains very uncertain.

AHIP CEO On The Budget Bill: ‘We Are Very Concerned About The Impact On Coverage’

During AHIP 2025, AHIP executives discussed the impact the proposed budget bill could have on Medicaid and the individual market.

Rising Healthcare Costs: What Employers Are Doing To Manage Expenses, Per Mercer

To deal with rising costs, employers are leveraging high performance networks, variable copay plans, and exclusive provider organization plans.

BioNTech To Buy CureVac In $1.25B Stock Deal That Would Also End mRNA Patent Dispute

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy candidates. Analysts say the M&A deal is a way to essentially settle out of court the ongoing mRNA patent dispute between the companies following some recent CureVac legal wins.

‘We Dissent’: NIH Workers Protest Trump Policies That ‘Harm The Health Of Americans’

The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH.

In Axing mRNA Contract, Trump Delivers Another Blow To US Biosecurity, Former Officials Say

The Trump administration has cancelled $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses.

Why CVS, Express Scripts Are Suing Over The Arkansas PBM Law

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express Scripts are suing, claiming the law is unconstitutional.

The GOP’s Budget Plan Is A Crisis In The Making For Hospitals

If enacted, the GOP’s spending bill could kick more than 10 million Americans off Medicaid. Experts are worried about the major spike in uncompensated care that hospitals would have to provide.

Pyx Health Acquires FarmboxRx With $47.5M Funding Boost

Acquiring FarmboxRx will help Pyx Health tackle food insecurity, a challenge many of its members struggle with.

HIPAA’s Blind Spot: It’s Time To Address Client-Side Attacks

While recognizing there is an issue is vital, too many healthcare organizations are counting on solutions that cannot provide a sufficient line of defense.

Analysis: The No Good, Very Bad Year For UnitedHealth

UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up, and mounting regulatory scrutiny.

Bird Flu Threat Still Looms, But HHS Just Canceled A Moderna Contract That Could Prepare For It

Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine candidate for avian influenza is on track for Phase 3 testing.